Small molecule · Agonist of mu-opioid receptor (OPRM1) · developed by Specgx Llc
ApprovedFDA, Mar 2010
1Registered trials
What is Hydromorphone?
Hydromorphone is a semi-synthetic opioid agonist that binds relatively selectively to the mu-opioid receptor, producing analgesia. It is used for management of severe pain and is also studied in opioid use disorder.
Summary written with AI from the sources listed at the end of this page.
Approved as Dilaudid, Exalgo, Hydromorphone Hydrochloride (March 1, 2010), NDA021217 · FDA label
✅ FDA-approved uses
Pain (Dilaudid)
Pain (Hydromorphone Hydrochloride)
From the indications section of the FDA label (version of Jul 15, 2026). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.